These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 22784117)

  • 21. Lessons from a naloxone kit.
    Sharma A
    CMAJ; 2019 Sep; 191(38):E1059-E1060. PubMed ID: 31548194
    [No Abstract]   [Full Text] [Related]  

  • 22. Early antidote use associated with noninvasive ventilation in prehospital treatment of methadone intoxication.
    Gonzva J; Prunet B; Deniel C; Benner P; Toppin F; Brun PM
    Am J Emerg Med; 2013 Feb; 31(2):448.e5-6. PubMed ID: 22944554
    [No Abstract]   [Full Text] [Related]  

  • 23. Expanded access to naloxone: options for critical response to the epidemic of opioid overdose mortality.
    Kim D; Irwin KS; Khoshnood K
    Am J Public Health; 2009 Mar; 99(3):402-7. PubMed ID: 19150908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of fatal opioid overdose.
    Beletsky L; Rich JD; Walley AY
    JAMA; 2012 Nov; 308(18):1863-4. PubMed ID: 23150005
    [No Abstract]   [Full Text] [Related]  

  • 25. Distribution of naloxone for overdose prevention to chronic pain patients.
    Coe MA; Walsh SL
    Prev Med; 2015 Nov; 80():41-3. PubMed ID: 26024850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Not Available].
    Benhaberou-Brun D
    Perspect Infirm; 2017; 14(2):35-37. PubMed ID: 29236368
    [No Abstract]   [Full Text] [Related]  

  • 27. Minimizing Opioid Overdose Deaths.
    Aschenbrenner DS
    Am J Nurs; 2020 Oct; 120(10):22. PubMed ID: 32976144
    [No Abstract]   [Full Text] [Related]  

  • 28. Naloxone Access and Use for Suspected Opioid Overdoses.
    Ann Emerg Med; 2017 Jul; 70(1):112-113. PubMed ID: 28645392
    [No Abstract]   [Full Text] [Related]  

  • 29. Impact of training for healthcare professionals on how to manage an opioid overdose with naloxone: effective, but dissemination is challenging.
    Mayet S; Manning V; Williams A; Loaring J; Strang J
    Int J Drug Policy; 2011 Jan; 22(1):9-15. PubMed ID: 21044832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetic Properties and Human Use Characteristics of an FDA-Approved Intranasal Naloxone Product for the Treatment of Opioid Overdose.
    Krieter P; Chiang N; Gyaw S; Skolnick P; Crystal R; Keegan F; Aker J; Beck M; Harris J
    J Clin Pharmacol; 2016 Oct; 56(10):1243-53. PubMed ID: 27145977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dying alone: the sad irrelevance of naloxone in the context of solitary opiate use.
    Wojcicki JM
    Addiction; 2019 Mar; 114(3):574-575. PubMed ID: 30461114
    [No Abstract]   [Full Text] [Related]  

  • 32. Managing opioid overdose in pregnancy with take-home naloxone.
    Blandthorn J; Bowman E; Leung L; Bonomo Y; Dietze P
    Aust N Z J Obstet Gynaecol; 2018 Aug; 58(4):460-462. PubMed ID: 29271100
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The conundrum of polysubstance overdose.
    Pergolizzi JV; Dahan A; LeQuang JA; Raffa RB
    J Clin Pharm Ther; 2021 Oct; 46(5):1189-1193. PubMed ID: 33460173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increasing Naloxone Awareness and Use: The Role of Health Care Practitioners.
    Adams JM
    JAMA; 2018 May; 319(20):2073-2074. PubMed ID: 29621389
    [No Abstract]   [Full Text] [Related]  

  • 35. Community-Based Response to Fentanyl Overdose Outbreak, San Francisco, 2015.
    Rowe C; Wheeler E; Stephen Jones T; Yeh C; Coffin PO
    J Urban Health; 2019 Feb; 96(1):6-11. PubMed ID: 29725887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DOH issues emergency regulations on expanding use of Narcan to prevent opioid overdose deaths.
    R I Med J (2013); 2014 Apr; 97(4):49. PubMed ID: 24960911
    [No Abstract]   [Full Text] [Related]  

  • 37. An increase in per-patient naloxone requirements in an opioid epidemic.
    Birmingham LE; Nielson JA
    Am J Emerg Med; 2017 Dec; 35(12):1958-1959. PubMed ID: 28633907
    [No Abstract]   [Full Text] [Related]  

  • 38. Intranasal Naloxone Administration.
    Ortega R; Nozari A; Baker W; Surani S; Edwards M
    N Engl J Med; 2021 Mar; 384(12):e44. PubMed ID: 33761209
    [No Abstract]   [Full Text] [Related]  

  • 39. Reversal of Pediatric Opioid Toxicity with Take-Home Naloxone: a Case Report.
    Lebin JA; Chen BC; Valento MJ
    J Med Toxicol; 2019 Apr; 15(2):134-135. PubMed ID: 30632074
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patient Simulation for Assessment of Layperson Management of Opioid Overdose With Intranasal Naloxone in a Recently Released Prisoner Cohort.
    Kobayashi L; Green TC; Bowman SE; Ray MC; McKenzie MS; Rich JD
    Simul Healthc; 2017 Feb; 12(1):22-27. PubMed ID: 28146450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.